-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRI-002 in Alzheimer’s Disease
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PRI-002 in Alzheimer's Disease Drug Details: PRI-002 is under development for the treatment of Alzheimer's...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Foscenvivint in Adrenocortical Carcinoma (Adrenal Cortex Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Foscenvivint in Adrenocortical Carcinoma (Adrenal Cortex Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Foscenvivint in Adrenocortical Carcinoma (Adrenal Cortex Cancer) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Foscenvivint in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Foscenvivint in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Foscenvivint in Solid Tumor Drug Details: Foscenvivint is under development for the...
-
Product Insights
Quarterly Chutneys & Relishes pricing trends in the United States
Consumers' preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices. GlobalData's new report titled "Quarterly Chutneys & Relishes pricing trends in the United States" serves as a crucial...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PRI-002
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry PRI-002 Drug Details PRI-002 is under development for the treatment of Alzheimer's disease. The...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PRI-724
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry PRI-724 Drug Details PRI-724 (OP-724) is under development for the treatment of HCV or...
-
Product Insights
Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Alpha Synuclein Drugs Development Market Report Overview Alpha-synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) is a protein normally found in cells all over the body. It is one of the key players in Parkinson’s. In Parkinson’s it forms clumps inside the specific nerve cells that produce the chemical dopamine. It is involved in the regulation of dopamine release and transport. It induces fibrillization of microtubule-associated protein tau. It...
-
Report Bundle
47% offESG in Sectors – Report Bundle (8 Reports)
Companies with good ESG practices reflect on their commitment to adopt environmentally conscious business decisions combined with strong social responsibility and corporate governance. ‘ESG in Sectors’ acts as a catalyst for creating business opportunities, attracting investors, increasing employee productivity, and reducing regulatory interventions. As a part of this bundle, you will gain access to in-depth insights available in the following reports: Thematic Research: ESG in Retail & Apparel Thematic Research: ESG in Financial Services Thematic Research: ESG in Construction Thematic...
-
Product Insights
Catenin Beta 1 (Beta Catenin or CTNNB1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Catenin Beta 1 pipeline drugs market research report outlays comprehensive information on the Catenin Beta 1 (Beta Catenin or CTNNB1) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players involved in Catenin Beta 1 (Beta Catenin or CTNNB1) targeted therapeutics development with respective active and dormant or discontinued projects.
-
Product Insights
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Primary biliary cirrhosis is a chronic disease of the liver that slowly destroys the bile ducts within the liver. Symptoms include fatigue, itchy skin, dry eyes, jaundice, swollen feet and ankles, pain in the upper right portion of the abdomen and diarrhea. Predisposing factors include age and history of infections. Treatment includes bile acid sequestrants and liver transplantation. The Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Drugs in Development market research report provides an overview of the Primary Biliary Cholangitis (Primary...